TickerSparkInvestor Intelligence
TickerSparkInvestor Intelligence
Community
Main Feed
Today's Market Intel
Top Stocks
AI-Curated Stock Lists
IPO Calendar
Upcoming Listings
Stock Teasers
The Stock Behind the Promo
Trending Stocks
Today's Big Movers
Earnings Coverage
Flashes & Deep Dives
Macro Updates
Economy & Markets
Stock Reports
AI Research Reports
Commentary
Opinionated Stock Takes
Custom Reports
Stock Deep Dives · Free to Try
AI Analyst
Agentic Chat · Free to Try
Watchlist
Track Your Stocks · Free
Spark Charts
AI Technical Analysis · Free to Try
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio · Pro
My Portfolio
Brokerage Connected · Pro
Custom Reports
Stock Deep Dives
AI Analyst
Agentic Chat
Watchlist
Your Stocks & Notes
Spark Charts
AI Technical Analysis
Intel Dashboard
Daily Trade Ideas
Trade Tracker
AI-Managed Portfolio
My Portfolio
Brokerage Connected
Account
Plan, Billing & Appearance
Log inCreate Account
← Back to TickerSpark
▌Earnings Flash·November 2, 2026

IDEXX Laboratories, Inc. (IDXX) jumps on earnings beats

IDEXX Laboratories, Inc. (IDXX) jumps 18.3% after reporting earnings beats, with investors reacting positively to stronger-than-expected results and improved outlook signals.

Earnings FlashIDXXHealthcareMedical - Diagnostics & Research
By TickerSpark·November 2, 2026·2 min read
IDEXX Laboratories, Inc. (IDXX) jumps on earnings beats
▌Key Takeaway
IDEXX Laboratories, Inc. (IDXX) delivered a broad earnings beat, posting EPS of $3.96 versus $3.73 expected and revenue of $1.21 billion versus $1.19 billion expected. The stock surged 18.29% in regular-session trading to $652.04, signaling that investors viewed the quarter as a strong confirmation of business momentum and execution.

IDEXX Laboratories, Inc. (IDXX) Earnings Beat, Stock Jumps

IDEXX Laboratories, Inc. (IDXX) beat estimates with EPS of $3.96 versus $3.73 and revenue of $1.21B versus $1.19B, while the stock jumped 18.29% in regular-session trading to $652.04.

Key Numbers

  • EPS: $3.96 actual versus $3.73 estimated, a clear beat.

§ Product

  • How It Works
  • Custom Reports
  • AI Analyst
  • Intel Dashboard
  • Spark Charts
  • Trade Tracker
  • My Portfolio
  • Plans

§ Research

  • Main Feed
  • Community
  • Stock Reports
  • Macro Updates
  • Blog

§ Company

  • About Us
  • Contact

§ Fine Print

  • Terms of Service
  • Privacy Policy
  • Full Disclaimer
  • Cookie Policy

Notice: All content and data on TickerSpark is for informational purposes only and does not constitute financial or investment advice. All investments involve risk. Please see our Full Disclaimer for more details.

© 2026 Maxwell Cyberlogic LLC

Not Investment Advice

Made in Delaware, USA

Revenue: $1.21B actual versus $1.19B estimated, also ahead of forecasts.
  • Stock reaction: IDXX rose 18.29% in regular-session trading from the prior close of $551.21.
  • Trading range: Shares moved between $621.22 and $662.98 during the regular session.
  • Earnings trend: IDXX exceeded EPS estimates in each of the five quarters listed.
  • A Broad Beat Extends IDXX's Earnings Streak

    This was a broad beat, not an EPS-only surprise. Both profit and revenue topped estimates, giving the result a stronger foundation than a cost-driven earnings gain. The $1.21B revenue result points to continued business momentum in the reported quarter.

    The 18.29% regular-session jump shows that investors treated the numbers as a meaningful positive. The move came on 442,955.156 shares, below the 553,104 average, so the price reaction was strong without unusually heavy volume.

    The earnings call matters for the link management draws between the $1.21B revenue result and $3.96 EPS result. That explanation will help investors judge whether the five-quarter beat streak reflects durable execution. IDXX posted EPS of $4.27 versus $3.94 in August and $3.47 versus $3.41 in May, reinforcing the recent pattern.

    Bottom line: IDXX delivered a broad earnings beat, and the 18.29% regular-session jump shows the market viewed the results as a meaningful sign of strength.

    Read the full IDXX research report
    ▌Common Questions

    Frequently asked questions

    +Why did IDEXX Laboratories stock jump after earnings?
    IDEXX Laboratories, Inc. (IDXX) rose 18.29% after reporting EPS of $3.96, above the $3.73 estimate, and revenue of $1.21 billion, above the $1.19 billion forecast. The market reacted positively because both profit and sales beat expectations, not just earnings alone.
    +Did IDEXX Laboratories beat on both earnings and revenue?
    Yes, IDEXX Laboratories, Inc. (IDXX) beat on both metrics in the reported quarter. EPS came in at $3.96 versus $3.73 expected, and revenue was $1.21 billion versus $1.19 billion expected.
    +How much did IDXX stock move after the earnings report?
    IDXX stock jumped 18.29% in regular-session trading to $652.04 from the prior close of $551.21. During the session, shares traded between $621.22 and $662.98.
    +Is IDEXX Laboratories continuing its earnings beat streak?
    Yes, the article says IDEXX Laboratories, Inc. (IDXX) has exceeded EPS estimates in each of the five quarters listed. Recent results also included EPS of $4.27 versus $3.94 in August and $3.47 versus $3.41 in May, reinforcing the pattern.
    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌The Full Report

    Want the full picture on IDXX?

    The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.

    Read the IDXX report →Get Full Access →

    Not ready to subscribe? ·

    ▌The Full Report

    Get the full IDXX research report

    • Analyst-grade deep dive
    • Charts, valuation, grades
    • Buy/sell price targets
    Read the IDXX report →
    ▌For Active Investors

    Smarter research, on every ticker

    • Daily market intelligence
    • On-demand stock analysis
    • AI analyst chat
    Get Full Access →

    Cancel anytime

    ▌The Daily Briefing · Free

    A new stock idea, every evening.

    One stock worth watching each weekday, free in your inbox.

    Creates a free TickerSpark account — newsletter included.

    or with email

    Daily market recap + weekly preview. One-click unsubscribe in every email.

    ▌More on IDXX

    More to read

    All articles
    IDEXX Laboratories, Inc. (IDXX) spikes on deep earnings beat
    IDXX

    IDEXX Laboratories, Inc. (IDXX) spikes on deep earnings beat

    IDEXX Laboratories, Inc. (IDXX) spiked after a strong Q3 beat, margin expansion, and raised 2026 guidance. This deep-dive looks beyond the headline, breaking down recurring diagnostics growth, international momentum, premium instrument placements, cash flow strength, and what the results may mean for the stock.

    Nov 2·6 min
    IDEXX Laboratories (IDXX): Premium Diagnostics, Rich Valuation
    IDXX

    IDEXX Laboratories (IDXX): Premium Diagnostics, Rich Valuation

    IDEXX posted double-digit Q3 growth and raised full-year guidance, but the stock already prices in much of that strength. Our stance is Hold with a fair value of $690.

    Nov 2·21 min
    IDEXX Laboratories, Inc. (IDXX) jumps 19% on earnings
    IDXX

    IDEXX Laboratories, Inc. (IDXX) jumps 19% on earnings

    IDEXX Laboratories, Inc. (IDXX) jumps after a strong Q3 report and higher full-year guidance. The veterinary diagnostics leader beat earnings estimates, posted double-digit revenue growth, and raised its 2026 outlook, fueling a sharp revaluation as investors responded to improving fundamentals.

    Nov 2·4 min